1999
DOI: 10.7863/jum.1999.18.11.779
|View full text |Cite
|
Sign up to set email alerts
|

Antenatal renal vein thrombosis after accidental electric shock in a pregnant woman.

Abstract: In utero RVT is not commonly suspected in the differential diagnosis of a renal mass in the fetus. To date, only six antenatal cases have been published. While the causes are diverse and the pathophysiologic mechanisms unclear, antenatal RVT is frequently associated with fetal distress. We report a new case of antenatal RVT, revealed by ultrasonography performed at 36 weeks' gestation for fetal distress, after an accidental electric shock 2 weeks earlier. CASE REPORTA 32 year old gravida 8 para 5 woman consult… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 11 publications
0
7
0
Order By: Relevance
“…There are no reports of prenatal intervention, and all therapeutic options have focused on supportive care in the neonatal period and on postnatal thrombolytic/anticoagulant drugs. Tissue plasminogen activator, unfractionated heparin, low-molecular-weight heparin and warfarin have all been used during the neonatal period in the reported cases of fetal RVT [6,19,21,24]. We could not find any report of maternal anticoagulation in the management of fetal RVT, and given the fact that heparin does not cross the placenta, the role of maternal anticoagulation may only have significance if the mother has an identified thrombophilia requiring anticoagulation.…”
Section: Discussionmentioning
confidence: 61%
See 4 more Smart Citations
“…There are no reports of prenatal intervention, and all therapeutic options have focused on supportive care in the neonatal period and on postnatal thrombolytic/anticoagulant drugs. Tissue plasminogen activator, unfractionated heparin, low-molecular-weight heparin and warfarin have all been used during the neonatal period in the reported cases of fetal RVT [6,19,21,24]. We could not find any report of maternal anticoagulation in the management of fetal RVT, and given the fact that heparin does not cross the placenta, the role of maternal anticoagulation may only have significance if the mother has an identified thrombophilia requiring anticoagulation.…”
Section: Discussionmentioning
confidence: 61%
“…Bleeding of the adrenal cortex occurred in 1 neonate who received a combination of tissue plasminogen activator and unfractionated heparin [6]. All of these cases survived; however, in 1 case, a nonfunctional kidney was found during follow-up evaluations [19]. The other cases did not receive any specific antithrombotic/anticoagulation therapy and underwent observational and supportive treatment such as hydration.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations